Global contract research organization specializing in translational oncology brings its preclinical model and biomarker capabilities to the coalition’s work advancing the adoption and qualification of new approach methodologies.Continue reading
Category Archives: AZBio News
NuvOx Therapeutics Receives FDA Fast Track Designation to NanO₂™ for the Treatment of Acute Ischemic Stroke
TUCSON, AZ, July 15, 2026 — NuvOx Therapeutics, Inc. (“NuvOx Therapeutics”, “NuvOx”, or the “Company”) today announces that its wholly owned subsidiary, NuvOx Pharma LLC, has been granted Fast Track designation for NanO₂™ by the U.S. Food and Drug Administration (“FDA”) for the treatment of adult patients presenting with acute ischemic stroke (“AIS”).
Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair
BioCentury co-founder succeeds Wain Fishburn, effective July 1Continue reading
TGen scientists identify nanobody that can be engineered to clear Alzheimer’s plaques
Fusion antibody was comparable to aducanumab treatment in clearing amyloid plaques in mice
AZBio Member Spotlight – Translational Genomics Research Institute (TGen), part of City of Hope
Based in Phoenix, Arizona, TGen’s mission is to translate research discoveries into improved diagnostics and therapies, shortening the path from scientific discovery to improved patient outcomes.Continue reading
How do different dementia pathologies interact in the mouse brain?
TGen-led study clarifies interactions between amyloid, tau, alpha-synuclein proteins
C-Path Awards $250,000 Grant to Advance New Treatment for Sepsis-Associated Neurocognitive Dysfunction
TUCSON, Ariz., July 9, 2026 — Critical Path Institute® (C-Path) has awarded a $250,000 research grant to Teresa Sanchez, Ph.D., of Weill Cornell Medicine, to support the development of a novel therapeutic approach for sepsis-associated neurocognitive dysfunction.Continue reading
Partnership Creates a Bridge Between Arizona and Taiwan Life Science Communities
The Arizona Bioindustry Association, Inc. (AZBio) and Bio Taiwan execute a Memorandum of Understanding focused on fostering collaborations between organizations in the Arizona and Taiwan life science sectors at the 2026 BIO International Convention in San Diego.
AZBio Member Spotlight – Valley Fever Solutions
Based in Arizona, Valley Fever Solutions is focused on resolving valley fever and from there, expanding to treat fungal infections more broadly, with a vision to redefine treatment standards in fungal disease.Continue reading